Skip to content

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Pfizer logo
PfizerPFE
$207.62B-0.2%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$1.23B+23.1%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$1.4B+2.9%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$699.61M-12.5%

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$3.53B+38.7%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's total assets?
Viking Therapeutics (VKTX) reported total assets of $608.24M in Q1 2026.
How has Viking Therapeutics's total assets changed year-over-year?
Viking Therapeutics's total assets decreased by 29.8% year-over-year, from $866.99M to $608.24M.
What is the long-term trend for Viking Therapeutics's total assets?
Over 5 years (2020 to 2025), Viking Therapeutics's total assets has grown at a 22.8% compound annual growth rate (CAGR), from $256.5M to $715.73M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.